Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
81 /100
CRITICAL RISK
Score updated Oct 13, 2026

NBY — NovaBay Pharmaceuticals Inc Dilution Risk Tracker

Track NBY dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track NBY — Get alerts when the score changes →

As of October 13, 2026, NovaBay Pharmaceuticals Inc (NBY) has a DilutionWatch DilutionScore of 81/100, rated CRITICAL dilution risk. NovaBay Pharmaceuticals Inc has a market capitalization of $51.92M, 50.62M shares outstanding, 2 institutional holders tracked. Stored dilution-related fields include ATM program capacity of $100.00M, 167.55B outstanding warrants.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
80
💰 Cash Runway
40
📊 Float Risk
100
⚠️ Warrant Exposure
90
🔄 Convertible Debt
40

Dilution Forecast

⛈️
Warning
High probability of dilution event
model est. 38%
📜 Warrant Exercise model 60%
• Massive warrant overhang: 331017% of shares outstanding
• Warrant risk score very high (90/100)
💰 Capital Raise model 18%
• Active ATM program with $100M remaining capacity
📉 Score Deterioration model 15%
• Score already CRITICAL (81/100) — events likely imminent
🔔 Track NBY — Get forecast alerts →

Market Data

Market Cap$51.92M
Shares Outstanding50.62M
Float2.62M
Cash$6.97M
Debt$106.0K
Short InterestN/A

Source-Backed Evidence Depth

This public preview uses stored DilutionWatch fields and linked SEC/market records only. Missing values are not estimated.

FieldCurrent ValueBasis
DilutionScore81/100DilutionWatch score record
Shares Outstanding50.62MVerified float table or market cache
Public Float2.62MVerified float table or market cache
Market Cap$51.92MMarket data cache
Cash Runway13.2 monthsDilutionWatch score inputs
Shelf CapacityNone in current score inputsSEC-derived dilution fields
ATM Capacity$100.00MSEC-derived dilution fields
Outstanding Warrants167.55BSEC-derived dilution fields

Recent source-backed SEC insight records available on this page: 7.

Recent SEC source mix: 4 4, 8-K 1, XBRL 2.

The page does not infer future share issuance, financing probability, cash needs, management intent, or price impact when source fields are absent.

Institutional Holdings

QoQ: ↓ 98.0% shares (2026Q1 vs prior)
2 institutional holders · 124.9K shares
#1 GOLDMAN SACHS GROUP INC 104.3K shares
#2 MORGAN STANLEY 20.5K shares

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

No current FINRA short-interest record is available for this ticker.

Recent SEC Activity

xbrl XBRL WARRANT 2026-07-30
xbrl XBRL CONVERTIBLE 2026-04-29
4 INSIDER TRANSACTION 2026-04-09
4 INSIDER TRANSACTION 2026-04-08
4 INSIDER TRANSACTION 2026-04-02
Full SEC filing analysis available with free account →

Recent News

No recent news available for this ticker.

Factual NBY Dilution Snapshot

NovaBay Pharmaceuticals Inc (NBY) has a DilutionScore of 81/100, rated Critical dilution risk. Score date: October 13, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

DilutionScore History — Last 90 Days

NBY's DilutionScore is currently 81/100 (Critical risk), with 4 score changes tracked over 89 days. The score improved from 70/100 (High risk).

Period Score Risk Level Duration
Oct 08 – Oct 13, 202681/100CRITICAL6 days
Sep 17 – Oct 07, 202670/100HIGH21 days
Aug 22 – Sep 16, 202658/100HIGH26 days
Aug 14 – Aug 21, 202670/100HIGH7 days
Jul 16 – Aug 13, 202649/100MEDIUM29 days

Score recalculated daily from SEC filings and market data. Sign up free for real-time score change alerts.

Share Dilution History

NBY shares outstanding have decreased 0.0% from 26.12M (Mar 2026) to 26.12M (Mar 2026). Each increase represents potential dilution to existing shareholders.

Date Shares Outstanding Public Float Change
Mar 25, 202626.12M2.62M▲ 21.24%
Mar 23, 202626.12M2.16M▲ 5.65%

Share counts sourced from verified regulatory filings. Increases indicate dilution events.

Track NBY Dilution Risk in Real-Time
DilutionWatch monitors SEC filings 24/7 and alerts you the moment NBY files a shelf registration, ATM offering, warrant notice, or convertible note. Free tier available — no credit card required.
Start Tracking NBY — Free
Email alert within minutes of any SEC filing Daily DilutionScore™ recalculation Score history & trend tracking Tracks 8,000+ tickers simultaneously

Related Stocks — CRITICAL Risk

Other CRITICAL dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Biotech / Pharma sector dilution risk overview

Browse all 8,490+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations